Guj. Inject(Ker)

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE659F01014
  • NSEID:
  • BSEID: 524238
INR
30.19
0.77 (2.62%)
BSENSE

Dec 05

BSE+NSE Vol: 1.05 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'17
Mar'16
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 3,231.11% vs 668.88% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 111.90% vs -733.08% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 787.62% vs 143.20% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 101.63% vs 1,757.47% in Mar 2023

Compare Profit and Loss Results of Guj. Inject(Ker)
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
5.00
24.00
-19.00
-79.17%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
5.00
24.00
-19.00
-79.17%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
1.00
-1.00
-100.00%
Raw Materials Consumed
5.00
18.00
-13.00
-72.22%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
1.00
-1.00
-100.00%
Operating Expenses
0.00
2.00
-2.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
5.00
26.00
-21.00
-80.77%
Operating Profit (PBDIT) excl Other Income
0.00
-2.00
2.00
100.00%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
0.00
-1.00
1.00
100.00%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
0.00
-1.00
1.00
100.00%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
0.00
-1.00
1.00
100.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
0.00
-1.00
1.00
100.00%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
0.00
-1.00
1.00
100.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-9.00
-1.00
-8.00
-800.00%
Profit Available for appropriations
-9.00
-3.00
-6.00
-200.00%
Appropriations
-9.00
-3.00
-6.00
-200.00%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.09
-2.33
2.42
103.86%
Profit And Loss - Net Sales
Net Sales 5.79 Cr
in Mar 2024

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2024 is 3,231.11% vs 668.88% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.04 Cr
in Mar 2024

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2024 is 111.90% vs -733.08% in Mar 2023

Profit And Loss - Interest
Interest 0.00 Cr
in Mar 2024

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2024 is 787.62% vs 143.20% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 0.08 Cr
in Mar 2024

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2024 is 101.63% vs 1,757.47% in Mar 2023